from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3880c/espL

LFCtreatmentdescriptionclass of inhibitor

-0.291

Amikacinug/mL Amikacintranslation

-1.324

Cap5-10ug/mL Capreomycintranslation

-0.998

Rox10-50 ug/mL Roxithromycintranslation

0.353

SM2-5 ug/mL Streptomycintranslation

2.284

Tet5-10 ug/mL Tetracyclinetranslation

-0.730

Rif0.2-5ug/mL Rifampicintranscription

-0.419

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.400

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.784

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.751

CPZ10-50 ug/mL Chlorpromazinerespiration

0.476

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.437

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.314

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.029

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.223

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.411

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.235

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.155

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.935

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.962

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.759

KCN5-20 ug/mL Potassium cyaniderespiration

-0.357

NaN30.2-2 mM Sodium aziderespiration

1.050

Nigericin50 uM Nigericinrespiration

0.265

TRC10-150 ug/mL Triclosanrespiration

2.076

TRZ10-25 ug/mL Thioridazinerespiration

1.086

Valinomycin0.5-10 uM Valinomycinrespiration

-0.206

ZnSO42 mM ZnSO4respiration

1.326

menadione6-10 ug/mL Menadionerespiration

0.279

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.612

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.076

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.341

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.746

NRP_1Non-replicating persistence stage 1dosRassociated

0.517

Amp0.2mg/mL AmpicillincellWall

0.297

Cephalexin20-100 ug/mL CephalexincellWall

-0.076

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.048

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.354

EMB10-20 ug/mL EthambutolcellWall

1.003

Eta12-40 ug/mL EthionamidecellWall

1.493

INH0.2-0.4 ug/mL IsoniazidcellWall

0.266

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.680

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.786

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.573

BZA0.12 mg/mL BenzamidearomaticAmides

-0.476

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.329

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.508

H2O24 mM hydrogen peroxideDNAdamaging

-1.045

Levo10 ug/mL LevofloxacinDNAdamaging

-0.691

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.485

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.177

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.481

UVUV-irradiationDNAdamaging

0.349

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.714

Antimycin12.5-50 ug/mL Antimycin A?

-0.370

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.320

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.547

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.091

PA8240.2-2 ug/mL PA-824?

0.131

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.193

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.303

Verapamil50 uM Verapamil?

-0.091

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.778

methoxatin10-20 ug/mL Methoxatin?